An Update To The Good Supply Practice For Pharmaceutical Distribution ("GSP")

CC
Clyde & Co

Contributor

Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
On 22 January 2013, the PRC Ministry of Health issued the revised Good Supply Practice for Pharmaceutical Distribution, which will take effect 1 June 2013.
China Food, Drugs, Healthcare, Life Sciences

On 22 January 2013, the PRC Ministry of Health issued the revised Good Supply Practice for Pharmaceutical Distribution ("Revised GSP"), which will take effect 1 June 2013.

In replacing the current GSP ("2000 GSP"), the Revised GSP provides stricter requirements for:

  • Warehousing Facilities (climate control and stock control systems);
  • Employee Qualifications (the company officers responsible for quality control, and retail operations, must be PRC-qualified pharmacists);
  • Document Retention; and
  • Pharmaceutical Quality Control.

The 2000 GSP will be "grand-fathered" for those PRC enterprises holding current GSP licenses, up to but not beyond renewal of current GSP or pharmaceutical trading licenses.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More